A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

NCT05249829 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

3548

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: mRNA-1273.529
BIOLOGICAL: mRNA-1273
BIOLOGICAL: mRNA-1273.214

Sponsor

ModernaTX, Inc.